Voreloxin

• Description :

  A first-in-class anticancer quinolone derivative that intercalates DNA and inhibits Topoisomerase II.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  401.4396

• Molecular Formula :

  C18H19N5O4S

• Notes :

  Research use only, not for human use.

• Receptor :

  Topo II

• CAS Number :

  175414-77-4